CAPTRUST Financial Advisors
FPRX

CAPTRUST Financial Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,396
Closed -$53K – 4828
2021
Q1 		$53K Buy
1,396
+1,296
+1,296% +$32.3K ﹤0.01% 2399
2020
Q4 		$2K Hold
100
– – ﹤0.01% 3200
2020
Q3 		$0 Hold
100
– – ﹤0.01% 3334
2020
Q2 		$1K Buy
+100
New +$412 ﹤0.01% 2778

CAPTRUST Financial Advisors's FPRX Position: Q2 2021 in Review

CAPTRUST Financial Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 1,396 shares — an estimated $53K sold.

CAPTRUST Financial Advisors first reported a position in FPRX in Q2 2020 and held it in 4 quarters. The position peaked at $53K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • CAPTRUST Financial Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,396 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $53K.
  • CAPTRUST Financial Advisors first reported a position in Five Prime Therapeutics, Inc. in Q2 2020 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Five Prime Therapeutics, Inc. position peaked at $53K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.